Americans spent $6 billion on the acid-reflux drug Nexium in 2012, making it the top-selling branded prescription medication. But other drugs work just as well and cost less, according to a ...

Pfizer has announced a deal with AstraZeneca for exclusive over-the-counter (OTC) rights to market Nexium for approved indications in the United States, Europe and the rest of the world.